Freedman Financial Associates’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-381
| Closed | -$31K | – | 53 |
|
|
2022
Q1 | $31K | Hold |
381
| – | – | 0.02% | 253 |
|
|
2021
Q4 | $34K | Hold |
381
| – | – | 0.02% | 248 |
|
|
2021
Q3 | $29K | Hold |
381
| – | – | 0.02% | 258 |
|
|
2021
Q2 | $32K | Hold |
381
| – | – | 0.02% | 245 |
|
|
2021
Q1 | $29K | Hold |
381
| – | – | 0.02% | 261 |
|
|
2020
Q4 | $33K | Buy |
+381
| New | +$33K | 0.03% | 235 |
|